Cooperative Agreement U01CA290611
Award Date
7/5/24
Completion Date
6/30/29
Dollars Obligated
$861K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Cooperative Agreement
Place of Performance
South Miami, FL 33146, USA
Similar Awards
This Cooperative Agreement award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) provides $946,500.00 to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) to test the effectiveness of pragmatic strategies to promote high-quality, evidence-based cancer survivorship care for rural adult cancer survivors in primary care practices. The project aims to assess the impact of interventions such as virtual scribes,...
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...
This $3,942,082 Cooperative Agreement award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support the Massachusetts Partnership for Community-Engaged Cancer Control Equity (MASS PCECCE) to advance cancer control equity. The key products and services to be delivered include: Building the capacity of community health centers to deliver evidence-based cancer screening and tobacco treatment programs, in partnership with community organizations to...
This Cooperative Agreement award, valued at $294,787, was made by the National Cancer Institute (NCI) under the Cancer Treatment Research (CFDA 93.395) program. The award supports the planning and development of a virtual exercise intervention trial aimed at preventing functional decline in cancer patients undergoing chemotherapy. Key components include: Assessing factors associated with functional decline in cancer survivors enrolled in the American Cancer Society Cancer Prevention Study-3...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the "Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients" (CFDA 93.376) program provides $459,993.00 in funding to the University of Illinois to support young breast cancer survivors, metastatic breast cancer patients, and their families. The award aims to increase support for caregivers and families, raise awareness of clinical trials, and...
This Cooperative Agreement award from the National Center for Chronic Disease Prevention and Health Promotion (part of the Centers for Disease Control and Prevention) under the Centers for Research and Demonstration for Health Promotion and Disease Prevention program (CFDA 93.135) provides $349,950 to the Regents of the University of Minnesota to conduct research on the impact of survivorship care plans on health outcomes in cancer survivors. The primary objective is to design, evaluate, and...
This federal Project Grant award of $357,694 from the National Cancer Institute (NCI), under the CFDA 93.393 Cancer Cause and Prevention Research program, supports research on understanding disparities in cancer outcomes related to health insurance coverage. The primary awardee, the University of Colorado-Denver, is building on an established data linkage between the Colorado Central Cancer Registry and the Colorado All-Payer Claims Database to examine the impact of factors like plan type,...
The National Cancer Institute (NCI) awarded a $3,998,962 Cooperative Agreement titled "Cancer Cause and Prevention Research" (CFDA 93.393) to Northwestern University. The award, effective September 6, 2024 through August 31, 2029, will establish the "Advancing Cancer Control Equity Research Through Transformative Solutions in Patient Navigation (ACCERT PN) Center" in Chicago. The ACCERT PN Center aims to develop community-engaged interventions, measures, and methods to...
This federal Project Grant award of $708,091 from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will fund the "Algorithm-Enabled Patients Activated in Cancer Care through Teams (A-PACT)" initiative. The goal of this 5-year project is to use machine learning algorithms to automatically identify high-risk cancer patients who can then be referred to a telephonic lay health worker-led intervention. This intervention aims to deliver...
This Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) provides $599,339 to the University of Miami to conduct a randomized clinical trial evaluating the efficacy of a multi-disciplinary telehealth intervention (HORIZONS) for improving quality of life, psychological distress, symptom burden, coping, and self-efficacy in patients with chronic graft-versus-host disease following hematopoietic stem cell transplantation....